1
Moderna's mRNA flu shot earns FDA approval after rollercoaster review
Moderna mRNA流感疫苗获批，老年人群迎来新选择，技术路线再获验证。
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
Moderna mRNA流感疫苗获批，老年人群迎来新选择，技术路线再获验证。
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.